OptumRx - Recall of Linezolid Injection by AuroMedics Pharma

Effective December 22, 2017

Author: Erica Lawrence/Friday, December 29, 2017/Categories: APCI Choice

On December 22, 2017, AuroMedics Pharma announced a voluntary recall of one lot of Linezolid Injection because of a product complaint in which one bag was found to contain white particulate matter identified as mold.

Per AuroMedics Pharma, use of a non-sterile injectable product could result in fatal infections.

OptumRx notified members who may be affected by this recall. These members were provided information to help them identify if their product is being recalled and advised not to use the recalled medicine. In the future, these members may inquire about the Linezolid Injection prescription(s) you dispensed.

*Please see attached for more information.

Comments are only visible to subscribers.